An Asian Regional Analysis of Cost-Effectiveness of Early Irbesartan Treatment versus Conventional Antihypertensive, Late Amlodipine, and Late Irbesartan Treatments in Patients with Type 2 Diabetes, Hypertension, and Nephropathy-Reference-Cited by-同舟云学术

An Asian Regional Analysis of Cost-Effectiveness of Early Irbesartan Treatment versus Conventional Antihypertensive, Late Amlodipine, and Late Irbesartan Treatments in Patients with Type 2 Diabetes, Hypertension, and Nephropathy

Published:2008-05 Issue:3 Volume:11 Page:354-364
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Annemans Lieven,Demarteau Nadia,Hu Shanlian,Lee Tae-Jin,Morad Zaher,Supaporn Thanom,Yang Wu-Chang,Palmer Andrew J.

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference42 articles.

1. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections;King;Diabetes Care,1998

2. Prevalence of type 2 diabetes in urban and rural Chinese populations in Qingdao, China;Dong;Diabet Med,2005

3. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030;Wild;Diabetes Care,2004

4. Diabetes epidemic in Malaysia;Mustaffa;Med J Malaysia,2004

5. Prevention of the progression of chronic kidney disease: practice in China;Wang;Kidney Int,2005

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost Effectiveness of ACEIs/ARBs versus Amlodipine Monotherapies: A Single-Center Retrospective Chart Review;Healthcare;2021-06-25

2. A Systematic Review of the Economic Burden of Type 2 Diabetes in Malaysia;International Journal of Environmental Research and Public Health;2020-08-07

3. From Evidence to Policy: Economic Evaluations of Healthcare in Malaysia: A Systematic Review;Value in Health Regional Issues;2020-05

4. Budget impact analysis of increasing prescription of renin-angiotensin system inhibitors drugs to standard anti-hypertensive treatments in patients with diabetes and hypertension in a hypothetical cohort of Malaysian population;PLOS ONE;2019-02-28

5. Provider costs for prevention and treatment of cardiovascular and related conditions in low- and middle-income countries: a systematic review;BMC Public Health;2015-11-26